Oral prophylaxis for preventing bacterial endocarditis
Oral prophylaxis for preventing bacterial endocarditis
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Caries in the primary teeth (24-months follow-up)
placebo |
nan | - | - | Not assessed |
|
Caries in permanent dentition (DMFS) (30 to 36 months)
placebo |
0.53 | - | - | Not assessed |
|
Elevated mutans streptococci levels ≥4 with caries screen (6 to 36 months)
placebo |
0.93 | - | - | Not assessed |
|
Adverse events
placebo |
nan | - | - | Not assessed |
|
Presence of new caries in the primary teeth (24-months follow-up)
no treatment |
1.0 | - | - | Not assessed |
|
Mutans streptococci prevalence (24-months follow-up)
no treatment |
1.26 | - | - | Not assessed |
|
Adverse events (24-months follow-up)
no treatment |
nan | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD008457 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7